Practical considerations for creating a strategic and proactive clinical safety and pharmacovigilance organization for the future

BACKGROUND: In 2012, Patient Safety (PS) in AstraZeneca was facing a situation with multiple challenges, scientifically and structurally. OBJECTIVE: To meet these and support AstraZeneca’s ambition to return to growth after years of patent expiry, we undertook a project to fundamentally revisit ways...

Descripción completa

Detalles Bibliográficos
Autores principales: Nord, Magnus, Ysander, Magnus, Sullivan, Tim, Patel, Mayur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461661/
https://www.ncbi.nlm.nih.gov/pubmed/33579878
http://dx.doi.org/10.3233/JRS-200082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461661/
https://www.ncbi.nlm.nih.gov/pubmed/33579878
http://dx.doi.org/10.3233/JRS-200082

Ejemplares similares